Evaluation of Response to Biosimilar Erythropoietin Alfa Therapy in Anemic Patients With Myelodysplastic Syndrome
NCT06764511
·
clinicaltrials.gov ↗
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Myelodysplastic Syndromes (MDS)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna